dc.contributor.author | Gallwitz, Baptist | |
dc.date.accessioned | 2023-03-07T10:17:37Z | |
dc.date.available | 2023-03-07T10:17:37Z | |
dc.date.issued | 2022 | |
dc.identifier.issn | 1467-7881 | |
dc.identifier.uri | http://hdl.handle.net/10900/137649 | |
dc.language.iso | en | de_DE |
dc.publisher | Wiley | de_DE |
dc.relation.uri | http://dx.doi.org/10.1111/obr.13372 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | The incretin/glucagon system as a target for pharmacotherapy of obesity | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20220728000000_02912 | |
utue.personen.roh | Del Prato, Stefano | |
utue.personen.roh | Gallwitz, Baptist | |
utue.personen.roh | Holst, Jens Juul | |
utue.personen.roh | Meier, Juris J. | |
dcterms.isPartOf.ZSTitelID | Obesity Reviews | de_DE |
dcterms.isPartOf.ZS-Issue | Article e13372 | de_DE |
dcterms.isPartOf.ZS-Volume | 23 (2) | de_DE |
utue.fakultaet | 04 Medizinische Fakultät | de_DE |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |